NCI Role in the Development of 50 Anticancer Drugs


Thanks to Marg Gartland from Dr. Robert Wittes's office, we have located a very useful document regarding the US government role in the development of anticancer drugs. The information below is taken from the NCI publication: Division of Cancer Treatment, Program Information Booklet, Fiscal Year 1995. The document identifies "All Anticancer Drugs That Have Received FDA Approval for Marketing in the United States" as of January 1, 1996. Apparently fifty of the seventy-seven anticancer drugs were were the product of NCI sponsored INDs (Investigational New Drugs). Here are the data, with the preceeding * indicating the product was based upon an NCI sponsored IND.


All Anticancer Drugs That Have Received FDA Approval for Marketing in the United States

(As of January 1, 1996)

Alkylating Agents-12

Mechlorethamine (Mustargen) (1949)
TEM (1953)
Busulfan (Myleran) (1954)
*Chlorambucil(Leukeran) (1957)
*Cyclophosphamide (Cytoxan) (1959)
*Thiotepa (1959)
Uracil Mustard (1962)
*Melphalan (L-PAM, Alkeran) (1959)
Pipobroman (Vercyte) (1966)
*Streptozotocin (Zanosar) (1982)
*Ifosfamide (Ifex) (1988)
*Melphalan (IV) (1993)

Antimetabolites-9

*Mercaptopurine (6-MP) (1953)
*Methotrexate (1953)
Fluorouracil (5-FU) (1962)
*Thioguanine (6-TG) (1966)
*Cytosine Arabinoside (Ara-C) (1969)
*FUDR (1970)
*Fludarabine Phosphate (1991)
*Pentostatin (1991)
*Chlorodeoxyadenosine (1992)

Plant Alkaloids and Antibiotics-15

Vinblastine (Velban) (1961)
*Vincristine (Oncovin) (1963)
*Actinomycin D (Cosmegen) (1964)
*Mithramycin (Mithracin) (1970)
*Bleomycin (Blenoxane) (1973)
*Doxorubicin (Adriamycin) (1974)
*Mitomycin C (Mutamycin) (1974)
*L-Asparaginase (Elspar) (1978)
*Daunomycin (Cerubidine) (1979)
*VP-16-213 (Etoposide) (1983)
Idarubicin (Idamycin) (1990)
*VM-26 (Teniposide) (1992)
*Taxol (Paclitaxel) (1992)
Navelibine (1994)
Doxorubicin Liposome Inj. (Doxil) (1995)

Synthetics-13

*Hydroxyurea (Hydrea) (1967)
*Procarbazine (Matulane) (1969)
*o-p -DDD (Lysodren, Mitotane) (1970)
*Dacarbazine (DTIC) (1975)
*CCNU (Lomustine) (1976)
*BCNU (Carmustine) (1977)
*Cis-diamminedichloroplatinum (Cis-platin) (1978)
*Mitoxantrone (Novantrone) (1988)
*Carboplatin (Paraplatin) (1989)
*Levamisole (Ergamisol) (1990)
*Hexamethylmelamine (Hexalen) (1990)
*All-trans retinoid Acid (Vessanoid) (1995)
*Porfimer sodium (Photofrin) (1995)

Hormones and Steroids-23

Ethinyl Estradiol (1949)
*DES (1950)
Testosterone (1950)
*Prednisone (1953)
*Fluoxymesterone (Halotestin) (1958)
*Dromostanolone (Drolban) (1961)
*Testolactone (Teslac) (1970)
Megestrol Acetate (Megace) (1971)
Tamoxifen (Nolvadex) (1978)
*Methyl Prednisolone
Methyltestosterone
*Prednisolone
Triamcinolone
Chlorotrianisene (TACE)
Hydroxyprogesterone (Delalutin)
Aminoglutethimide (Cytadren)
Estramustine (Emcyt)
Medroxyprogesterone Acetate (Depo-Provera, Provera)
Leuprolide (Lupron) (1985)
Flutamide (Eulexin( (1989)
*Zoladex (1989)
Bicalutamide (Casodex) (1995)
Anastrozole (Arimidex) (1995)

Biologicals-5

*Alpha Interferon (Intron A, Roferon-A) (1986)
*BCG (TheraCys, TICE) (1990)
*G-CSF (1991)
*GM-CSF (1991)
*Interleukin-2 (Proleukin) (1992)

Grand Total-77

*IND sponsored by the National Cancer Institute (total INDs sponsored by NCI=50)


Corrections or suggestions to Thiru Balasubramaniam thiru@cptech.org

| CPT home page | CPT Health Care and Intellectual Property page | U.S. Government Role in Drug Development |